AI Prospecting for Quest Diagnostics
Company data:
Company size:
56000 employeesWebsite URL:
https://www.questdiagnostics.comIndustry
HealthcareHeadquarters:
500 Plaza Drive, Secaucus, NJ 07094, USAInvestment round:
Publicly Traded (NYSE: DGX)ARR:
$10 billionKey stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Quest Diagnostics
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Quest Diagnostics has launched the new AD-Detect™ blood test to aid in confirming Alzheimer's Disease, announced on April 9, 2025. This test is designed to improve diagnosis and management of Alzheimer's patients[1][4].
Quest Diagnostics will release its first quarter 2025 financial results on April 22, 2025, with telephone replays available until May 6, 2025[3][4].
Quest Diagnostics reported strong financial results for the fourth quarter and full year 2024, with a 14.5% revenue increase to $2.62 billion and full-year revenues of $9.87 billion, up 6.7% from 2023. The company also completed eight acquisitions, expanded its advanced diagnostics portfolio, and increased its quarterly dividend by 6.7% to $0.80 per share[5].
Open job positions at Quest Diagnostics
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Internal Account Manager
Physician Account Manager
Internal Account Manager
